Avanos Medical (AVNS) Asset Writedowns and Impairment (2024)
Avanos Medical's (AVNS) quarterly Asset Writedowns and Impairment came in at $336.5 million in Q4 2024.
Avanos Medical (AVNS) Asset Writedowns and Impairment (2024) Analysis & Trends
Avanos Medical has disclosed Asset Writedowns and Impairment across 1 years of filings, most recently posting $336.5 million for Q4 2024.
- Asset Writedowns and Impairment for Q4 2024 came in at $336.5 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2024 was $336.5 million (changed N/A YoY), and the FY2025 annual result was $77.0 million, down 82.37% from the prior year.
- Asset Writedowns and Impairment came in at $336.5 million for Q4 2024 at Avanos Medical.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $336.5 million in Q4 2024 to a low of $336.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Avanos Medical | 1.16 Bn | 1.10 Bn | 94.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 336.50 Mn |
| Dec 31, 2024 | 336.50 Mn |